EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Sort by

Case T-30/22: Order of the General Court of 20 July 2022 — Sanoptis v EUIPO — Synoptis Pharma (SANOPTIS) (EU trade mark — Opposition proceedings — Withdrawal of the application for registration — No need to adjudicate)

CELEX number:
62022TB0030
Form:
Judicial information
Author:
General Court
Date of document:
20/07/2022
Number of pages:
1

Case T-30/22: Action brought on 18 January 2022 — Sanoptis v EUIPO — Synoptis Pharma (SANOPTIS)

CELEX number:
62022TN0030
Form:
Judicial information
Author:
General Court
Date of document:
18/01/2022
Number of pages:
2

Non-opposition to a notified concentration (Case M.10590 – PAI PARTNERS / OTPP / VEONET) (Text with EEA relevance) 2022/C 70/01

C/2022/750

CELEX number:
52022M10590(01)
Form:
Notice
Author:
European Commission, Directorate-General for Competition
Date of document:
03/02/2022
Number of pages:
1

Prior notification of a concentration (Case M.10590 – PAI PARTNERS / OTPP / VEONET) Candidate case for simplified procedure (Text with EEA relevance) 2022/C 25/05

PUB/2022/19

CELEX number:
52022M10590
Form:
Announcements
Author:
European Commission, Directorate-General for Competition
Date of document:
18/01/2022; Date of publication
Number of pages:
2

Case T-501/20: Judgment of the General Court of 30 June 2021 — Makk v EUIPO — Ubati Luxury Cosmetics (PANTA RHEI) (EU trade mark — Opposition proceedings — International registration designating the European Union — Word mark PANTA RHEI — Earlier EU word mark PANTA RHEI — Relative ground for refusal — Likelihood of confusion — Similarity of the goods — Article 8(1)(b) of Regulation (EU) 2017/1001)

CELEX number:
62020TA0501
Form:
Judicial information
Author:
General Court
Date of document:
30/06/2021
Number of pages:
1

Case T-501/20: Action brought on 10 August 2020 — Makk v EUIPO — Ubati Luxury Cosmetics (PANTA RHEI)

CELEX number:
62020TN0501
Form:
Judicial information
Author:
General Court
Date of document:
10/08/2020
Number of pages:
1

Non-opposition to a notified concentration (Case M.9812 – Verily Life Sciences/Santen Pharmaceutical/JV) (Text with EEA relevance) 2020/C 263/01

C/2020/5467

CELEX number:
52020M9812(01)
Form:
Notice
Author:
European Commission, Directorate-General for Competition
Date of document:
03/08/2020
Number of pages:
1

Prior notification of a concentration (Case M.9812 – Verily Life Sciences/Santen Pharmaceutical/JV) Candidate case for simplified procedure (Text with EEA relevance) 2020/C 235/04

PUB/2020/570

CELEX number:
52020M9812
Form:
Announcements
Author:
European Commission, Directorate-General for Competition
Date of document:
17/07/2020; Date of publication
Number of pages:
2

Decision of the EEA Joint Committee No 14/2018 of 9 February 2018 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/2050]

Legal status of the documentIn force

CELEX number:
22019D2050
Form:
Decision adopted by bodies created by international agreements
Author:
EEA Joint Committee
Date of document:
09/02/2018; Date of adoption
Number of pages:
1

Case T-84/15: Action brought on 18 February 2015 — Laboratorios Thea v OHIM — Sebapharma (Sebacur)

CELEX number:
62015TN0084
Form:
Judicial information
Author:
General Court
Date of document:
18/02/2015
Number of pages:
2
Sort by
2
Domain: All, EUROVOC descriptor: eye disease, Search language: English